THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY - Sorbonne Université Access content directly
Conference Papers Year : 2021

Dates and versions

hal-03969938 , version 1 (02-02-2023)

Identifiers

Cite

Eric Bruckert, Sonia Caprio, Albert Wiegman, Min-Ji Charng, A Zarate-Morales Cezar, et al.. THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY. 70th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), May 2021, Virtuel - Online, France. ⟨10.1161/ATVBAHA.122.317793⟩. ⟨hal-03969938⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More